Home LiteratureArticle Details
PMID: 15951834 Published · ppublish English Journal Article

Therapeutic targeting of CCR1 attenuates established chronic fungal asthma in mice.

British journal of pharmacology ·Vol. 145 ·No. 8 ·2005-08-00 ·Pages 1160-72

Carpenter KJ, Ewing JL, Schuh JM, Ness TL, Kunkel SL, Aparici M, Miralpeix M, Hogaboam CM

Abstract

CC chemokine receptor 1 (CCR1) represents a promising target in chronic airway inflammation and remodeling due to fungus-associated allergic asthma. The present study addressed the therapeutic effect of a nonpeptide CCR1 antagonist, BX-471, in a model of chronic fungal asthma induced by Aspergillus fumigatus conidia. BX-471 treatment of isolated macrophages inhibited CCL22 and TNF-alpha and promoted IL-10 release. BX-471 also increased toll like receptor-9 (TLR9) and decreased TLR2 and TLR6 expression in these cells. When administered daily by intraperitoneal injection, from days 15 to 30 after the initiation of chronic fungal asthma, BX-471 (3, 10, or 30 mg kg(-1)) dose-dependently reduced airway inflammation, hyper-responsiveness, and remodeling at day 30 after conidia challenge. The maximal therapeutic effect was observed at the 10 mg kg(-1) dose. In summary, the therapeutic administration of BX-471 significantly attenuated experimental fungal asthma via its effects on both innate and adaptive immune processes.

MeSH Terms
Animals Aspergillosis/drug therapy,immunology,microbiology Aspergillus fumigatus/immunology Asthma/drug therapy,immunology,microbiology Chronic Disease Disease Models, Animal Dose-Response Relationship, Drug Female Immunity, Innate/drug effects Macrophages, Peritoneal/drug effects,metabolism Mice Mice, Inbred BALB C Mice, Inbred CBA Phenylurea Compounds/therapeutic use Piperidines/therapeutic use Receptors, CCR1 Receptors, Chemokine/antagonists & inhibitors
Chemicals
Ccr1 protein, mouse Phenylurea Compounds Piperidines Receptors, CCR1 Receptors, Chemokine BX 471
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Carpenter Kristin J
Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Ewing Jillian L
Schuh Jane M
Ness Traci L
Kunkel Steven L
Aparici Monica
Miralpeix Montserrat
Hogaboam Cory M
References (45)
45 references, click to expand
  1. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis.
    J Immunol. 1999 Dec 1;163(11):6086-94 PMID: 10570298
  2. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma.
    J Immunol. 2004 Mar 1;172(5):2739-43 PMID: 14978071
  3. Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus.
    Am J Pathol. 2000 Feb;156(2):723-32 PMID: 10666400
  4. Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor.
    Eur J Pharmacol. 2000 Feb 11;389(1):41-9 PMID: 10686294
  5. Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1.
    J Biol Chem. 2000 Jun 23;275(25):19000-8 PMID: 10748002
  6. Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease.
    J Immunol. 2000 Aug 1;165(3):1564-72 PMID: 10903765
  7. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.
    J Biol Chem. 2000 Aug 25;275(34):25985-92 PMID: 10854442
  8. Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression.
    J Immunol. 2000 Nov 15;165(10):5839-46 PMID: 11067944
  9. Antifungal and airway remodeling roles for murine monocyte chemoattractant protein-1/CCL2 during pulmonary exposure to Asperigillus fumigatus conidia.
    J Immunol. 2001 Feb 1;166(3):1832-42 PMID: 11160230
  10. CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model.
    Immunol Lett. 2001 Apr 2;76(3):193-201 PMID: 11306147
  11. A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection.
    J Biol Chem. 2001 Feb 9;276(6):4199-204 PMID: 11054419
  12. Regulation of chemokine receptor expression in eosinophils.
    Int Arch Allergy Immunol. 2001;125 Suppl 1:29-32 PMID: 11408769
  13. Chemokine receptors in airway disease: which receptors to target?
    Pulm Pharmacol Ther. 2001;14(3):193-202 PMID: 11448146
  14. Cytokine-directed therapies for asthma.
    J Allergy Clin Immunol. 2001 Aug;108(2 Suppl):S72-6 PMID: 11498676
  15. Toll-like receptors as sensors of pathogens.
    Pediatr Res. 2001 Sep;50(3):315-21 PMID: 11518816
  16. IL-18 modulates chronic fungal asthma in a murine model; putative involvement of Toll-like receptor-2.
    Inflamm Res. 2001 Nov;50(11):552-60 PMID: 11766995
  17. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.
    J Clin Invest. 2002 Jan;109(2):251-9 PMID: 11805137
  18. The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice.
    FASEB J. 2002 Feb;16(2):228-30 PMID: 11744622
  19. Cytokines and chemoattractants in allergic inflammation.
    Mol Immunol. 2002 May;38(12-13):881-5 PMID: 12009564
  20. Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4-/- mice.
    FASEB J. 2002 Aug;16(10):1313-5 PMID: 12154006
  21. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus.
    J Biol Chem. 2002 Oct 18;277(42):39320-6 PMID: 12171914
  22. Transient lung-specific expression of the chemokine KC improves outcome in invasive aspergillosis.
    Am J Respir Crit Care Med. 2002 Nov 1;166(9):1263-8 PMID: 12403697
  23. Cytokines and chemokines in allergic bronchopulmonary aspergillosis (ABPA) and experimental Aspergillus-induced allergic airway or asthmatic disease.
    Front Biosci. 2003 Jan 1;8:e147-56 PMID: 12456354
  24. Strategies for chemokine antagonists as therapeutics.
    Semin Immunol. 2003 Feb;15(1):57-65 PMID: 12495641
  25. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo.
    J Immunol. 2004 Mar 1;172(5):3059-69 PMID: 14978111
  26. Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways.
    Eur J Immunol. 2004 Apr;34(4):1196-207 PMID: 15048731
  27. Toll-like receptor 2 as a major gene for asthma in children of European farmers.
    J Allergy Clin Immunol. 2004 Mar;113(3):482-8 PMID: 15007351
  28. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.
    J Am Soc Nephrol. 2004 Jun;15(6):1504-13 PMID: 15153561
  29. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase.
    J Clin Invest. 2004 Jul;114(2):270-9 PMID: 15254594
  30. A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1).
    Immunol Invest. 1992 Feb;21(1):39-45 PMID: 1548046
  31. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis.
    J Exp Med. 1997 Mar 17;185(6):1089-99 PMID: 9091582
  32. Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor.
    J Biol Chem. 1998 Jun 19;273(25):15687-92 PMID: 9624164
  33. Immunomodulatory role of C10 chemokine in a murine model of allergic bronchopulmonary aspergillosis.
    J Immunol. 1999 May 15;162(10):6071-9 PMID: 10229848
  34. TLR6: A novel member of an expanding toll-like receptor family.
    Gene. 1999 Apr 29;231(1-2):59-65 PMID: 10231569
  35. The chemokine system: novel broad-spectrum therapeutic targets.
    Curr Opin Pharmacol. 2001 Aug;1(4):417-24 PMID: 11710742
  36. Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors.
    J Am Soc Nephrol. 2003 Feb;14(2):317-26 PMID: 12538732
  37. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates.
    Infect Immun. 2003 Jun;71(6):3034-42 PMID: 12761080
  38. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages.
    Cell Microbiol. 2003 Aug;5(8):561-70 PMID: 12864815
  39. Chemokines in allergic airway disease.
    Curr Opin Pharmacol. 2003 Aug;3(4):443-8 PMID: 12901955
  40. Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference.
    Clin Infect Dis. 2003 Oct 1;37 Suppl 3:S225-64 PMID: 12975753
  41. Immunomodulatory role of CXCR2 during experimental septic peritonitis.
    J Immunol. 2003 Oct 1;171(7):3775-84 PMID: 14500678
  42. Chemokines in allergy.
    Curr Drug Targets Inflamm Allergy. 2002 Mar;1(1):109-16 PMID: 14561210
  43. Chemokines and cytokines: axis and allies in asthma and allergy.
    Cytokine Growth Factor Rev. 2003 Dec;14(6):503-10 PMID: 14563352
  44. Intrapulmonary targeting of RANTES/CCL5-responsive cells prevents chronic fungal asthma.
    Eur J Immunol. 2003 Nov;33(11):3080-90 PMID: 14579276
  45. Discovery of novel non-peptide CCR1 receptor antagonists.
    J Med Chem. 1999 Nov 4;42(22):4680-94 PMID: 10579830
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
2005-08-00
Pages
1160-72
Language
English
Region
England
NLM ID
7502536
PMCID
PMC1576221
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com